GABA B receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. GABA B receptors are abundant on dendritic spines, where they dampen postsynaptic excitability and inhibit Ca 2+ influx through NMDA receptors when activated by spillover of GABA from neighboring GABAergic terminals. Here, we show that an excitatory signaling cascade enables spines to counteract this GABA B -mediated inhibition. We found that NMDA application to cultured hippocampal neurons promotes dynamindependent endocytosis of GABA B receptors. NMDA-dependent internalization of GABA B receptors requires activation of Ca 2+ /Calmodulindependent protein kinase II (CaMKII), which associates with GABA B receptors in vivo and phosphorylates serine 867 (S867) in the intracellular C terminus of the GABA B1 subunit. Blockade of either CaMKII or phosphorylation of S867 renders GABA B receptors refractory to NMDA-mediated internalization. Time-lapse two-photon imaging of organotypic hippocampal slices reveals that activation of NMDA receptors removes GABA B receptors within minutes from the surface of dendritic spines and shafts. NMDA-dependent S867 phosphorylation and internalization is predominantly detectable with the GABA B1b subunit isoform, which is the isoform that clusters with inhibitory effector K + channels in the spines. Consistent with this, NMDA receptor activation in neurons impairs the ability of GABA B receptors to activate K + channels. Thus, our data support that NMDA receptor activity endocytoses postsynaptic GABA B receptors through CaMKIImediated phosphorylation of S867. This provides a means to spare NMDA receptors at individual glutamatergic synapses from reciprocal inhibition through GABA B receptors.
GABA B receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. GABA B receptors are abundant on dendritic spines, where they dampen postsynaptic excitability and inhibit Ca 2+ influx through NMDA receptors when activated by spillover of GABA from neighboring GABAergic terminals. Here, we show that an excitatory signaling cascade enables spines to counteract this GABA B -mediated inhibition. We found that NMDA application to cultured hippocampal neurons promotes dynamindependent endocytosis of GABA B receptors. NMDA-dependent internalization of GABA B receptors requires activation of Ca 2+ /Calmodulindependent protein kinase II (CaMKII), which associates with GABA B receptors in vivo and phosphorylates serine 867 (S867) in the intracellular C terminus of the GABA B1 subunit. Blockade of either CaMKII or phosphorylation of S867 renders GABA B receptors refractory to NMDA-mediated internalization. Time-lapse two-photon imaging of organotypic hippocampal slices reveals that activation of NMDA receptors removes GABA B receptors within minutes from the surface of dendritic spines and shafts. NMDA-dependent S867 phosphorylation and internalization is predominantly detectable with the GABA B1b subunit isoform, which is the isoform that clusters with inhibitory effector K + channels in the spines. Consistent with this, NMDA receptor activation in neurons impairs the ability of GABA B receptors to activate K + channels. Thus, our data support that NMDA receptor activity endocytoses postsynaptic GABA B receptors through CaMKIImediated phosphorylation of S867. This provides a means to spare NMDA receptors at individual glutamatergic synapses from reciprocal inhibition through GABA B receptors.
γ-aminobutyric acid | spines | trafficking | synaptic plasticity | GABAB G ABA B receptors modulate the excitability of neurons throughout the brain. They are therapeutic targets for a variety of disorders, including cognitive impairments, addiction, anxiety, depression, and epilepsy (1) . Depending on their subcellular localization GABA B receptors exert distinct regulatory effects on synaptic transmission (2) (3) (4) . Presynaptic GABA B receptors inhibit neurotransmitter release (5, 6) . Postsynaptic GABA B receptors dampen neuronal excitability by gating Kir3-type K + channels, which generates slow inhibitory postsynaptic potentials and local shunting (7) . Molecular diversity in the GABA B system arises from the GABA B1a and GABA B1b subunit isoforms, both of which combine with GABA B2 subunits to form heteromeric GABA B(1a,2) and GABA B(1b,2) receptors (8) . Genetically modified mice revealed that the two receptors convey nonredundant synaptic functions at glutamatergic synapses, owing to their differing distribution to axonal and dendritic compartments (3, 9) . Selectively GABA B(1a,2) receptors control the release of glutamate, whereas predominantly GABA B(1b,2) receptors activate postsynaptic Kir3 channels in dendritic spines (10) (11) (12) . Activation of GABA B receptors on spines inhibits NMDA receptors through hyperpolarization and the PKA pathway, which enhances Mg 2+ block (13, 14) and reduces Ca 2+ permeability (15) of NMDA receptors. Reciprocally, there is evidence that glutamate receptors decrease surface expression of GABA B receptors (16) (17) (18) . This supports that glutamate receptors and GABA B receptors cross-talk in dendrites and spines.
Neither the glutamate receptors nor the signaling pathways controlling surface availability of GABA B receptors have yet been identified. Here we show that NMDA receptor-dependent phosphorylation via CaMKII targets GABA B receptors for internalization. This postsynaptic regulation of GABA B receptors has implications for the control of local excitability and Ca 2+ -dependent neuronal functions.
Results

NMDA Receptors
Mediate GABA B Receptor Internalization. We used transfected cultured hippocampal neurons to identify the glutamate receptors regulating cell surface expression of GABA B receptors. Robust cell surface expression of tagged GABA B1b subunits (HA-GB1b-eGFP) was observed upon cotransfection with GABA B2 subunits (Fig. 1A) , which are mandatory for GABA B1 surface expression (8, 19, 20) . GABA B1b surface expression was monitored by immunolabeling of the extracellular HA-tag before permeabilization of cells (red fluorescence). Total GABA B1b expression was monitored by immunolabeling of the intracellular eGFP-tag after permeabilization of cells (green fluorescence). To quantify the level of surface GABA B1b protein, we calculated the ratio of red to green fluorescence intensity ( Fig. 1  B and C) . Upon glutamate treatment (50 μM glutamate/5 μM glycine for 30 min), surface GABA B1b protein was significantly reduced (41.4 ± 5.3% of control, n = 10, P < 0.001), consistent with published data (18) . The NMDA receptor antagonist APV (100 μM for 2 h) prevented the glutamate-induced decrease in surface GABA B1b protein (98.4 ± 12.6% of control, n = 9, P > 0.05). We tested whether a selective activation of NMDA receptors is sufficient to decrease surface GABA B1b protein. Following NMDA treatment (75 μM NMDA/5 μM glycine for 3 min) and recovery in conditioned medium for 27 min, surface GABA B1b protein was significantly reduced (54.8 ± 3.2% of control, n = 10, Author contributions: N.G., S.A.A., N.H., R.T., T.R., R.S., M.G., P.J., E.C., and B.B. designed research; N.G., S.A.A., N.H., R.T., T.R., R.S., S.M., and E.C. performed research; T.G.O. contributed new reagents/analytic tools; N.G., S.A.A., N.H., R.T., T.R., R.S., M.G., S.M., P.J., and E.C. analyzed data; and N.G., M.G., and B.B. wrote the paper.
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1000909107/-/DCSupplemental. P < 0.01). Heteromerization with GABA B2 is mandatory for exit of GABA B1 from the endoplasmic reticulum and for receptor function (19, 20) . As expected from the assembly with GABA B1 , surface GABA B2 protein was also significantly decreased following glutamate or NMDA application, and this decrease was prevented by APV (Fig. S1A) . We also observed a trend toward decreased surface GABA B1a protein in response to glutamate or NMDA but this did not reach statistical significance (Fig. S1B) . Although surface biotinylation experiments in cultured cortical neurons revealed significant internalization of endogenous GABA B1b as well as GABA B1a protein in response to NMDA (GB1b NMDA: 52.9 ± 9.9% of control, n = 3, P < 0.01; GB1a NMDA: 74.1 ± 3.4% of control, n = 3, P < 0.05; Fig. 2B ), significantly more GABA B1b than GABA B1a protein was internalized (P < 0.05; ANOVA with Bonferroni test). Endogenous surface GABA B2 protein was also significantly down-regulated following NMDA treatment (57.0 ± 6.0% of control, n = 3, P < 0.001; Fig. 2B ). This supports that preferentially GABA B(1b,2) receptors are removed from the cell surface in response to NMDA application, possibly as a consequence of their selective localization in the somatodendritic compartment (10) .
We examined whether the decrease in surface GABA B1b protein following glutamate or NMDA treatment is due to endocytosis. We observed basal endocytosis of surface GABA B1b protein under control conditions (Fig. S2A) , as previously reported (21) . Glutamate or NMDA treatment visibly increased endocytosis of GABA B1b protein, which was inhibited in the presence of APV (Fig. S2A) . Constitutively internalized GABA B1b protein colocalized with Rab11-eGFP (22, 23) , a marker for recycling endosomes (Fig. S2B) . Following glutamate or NMDA treatment, a fraction of internalized GABA B1b protein segregated into structures devoid of Rab11-eGFP, possibly indicating GABA B1b protein targeted for degradation (24, 25) . Preincubation of neurons with dynasore (80 μM for 15 min), a cell-permeable inhibitor of dynamin-dependent endocytosis (26) , interfered with the NMDA-mediated removal of surface GABA B1b protein (NMDA: 58.8 ± 5.4% of control, n = 8, P < 0.05; NMDA + dynasore: 105 ± 10% of control, n = 10, P > 0.05; dynasore: 98.4 ± 9.0% of control, n = 9, P > 0.05; Fig. 1C ). Agonists accelerate basal endocytosis of GABA B receptors (25) . Antagonizing GABA B receptor activity with CGP54626A (2 μM for 10 min) did not attenuate NMDAmediated removal of surface GABA B1b protein (NMDA + CGP54626A: 60.2 ± 9.6% of control, n = 10, P < 0.05; Fig. 1C ). Thus NMDA receptor activation triggers dynamin-dependent endocytosis of GABA B receptors, irrespective of whether GABA B receptors are active or not. Data are means ± SEM, n = 9-10, **P < 0.01. (B) NMDAmediated removal of endogenous surface GABA B receptors. Live cortical neurons were treated at DIV14 as indicated and then biotinylated. Cell homogenates (total) and avidin-purified cell surface proteins (surf) were probed on Western blots with anti-GABA B1 (anti-GB1) and anti-GABA B2 (anti-GB2) antibodies. While all GABA B subunits were removed from the cell surface in response to NMDA, GABA B1b was more efficiently removed than GABA B1a (P < 0.05). NMDA-mediated removal of surface protein was inhibited by KN-93. Anti-tubulin antibodies were used as a control. Of note, we consistently observed that significantly more GABA B1b protein was detected at the cell surface under control conditions, albeit GABA B1a is more abundant in cortical neurons (GB1a-to-GB1b ratio: surface, 0.71 ± 0.08; total, 1.32 ± 0.05; n = 3, P < 0.01). (C) CaMKII interacts with GABA B receptors in the brain. Anti-GB1 and anti-GB2 antibodies coimmunoprecipitated CaMKII from purified mouse brain membranes, whereas control rabbit (serum rb) or guinea-pig serum (serum gp) did not. (D) Pull-down assays with GST-fusion proteins containing the entire C-terminal domain of GABA B1 (GST-GB1) or GABA B2 (GST-GB2) and whole-brain lysates. CaMKII bound to a larger extent to GST-GB1 than to GST-GB2. Control assays were with glutathione beads alone or with beads together with GST protein. (E) In vitro phosphorylation of GST-fusion proteins with [γ-
32 P]-ATP in the presence or absence of recombinant CaMKII. Phosphorylated proteins were separated by SDS/PAGE and exposed to autoradiography. CaMKII specifically phosphorylated GST-GB1 but not GST-GB2 or GST alone. Coomassie blue staining controlled for loading. The GST-GB2 fusion protein tended to degrade (50) .
Removal of Surface GABA B Receptors Requires CaMKII Activity.
NMDA failed to reduce surface GABA B1b protein in transfected hippocampal neurons in the presence of the membrane-permeable Ca 2+ -chelator EGTA-AM (100 μM for 10 min; NMDA: 51.7 ± 6.7% of control, n = 10, P < 0.01; NMDA + EGTA-AM: 83.4 ± 9.0% of control, n = 9, P > 0.05; Fig. 2A ). NMDA also failed to reduce surface GABA B1b protein in the presence of the CaMKII inhibitor KN-93 (10 μM for 10 min; NMDA + KN-93: 85.6 ± 11.1% of control, n = 10, P > 0.05), implicating activation of CaMKII by NMDA receptors (27) in the removal of surface GABA B1b . Likewise, KN-93 also prevented the NMDA-induced decrease of exogenous GABA B2 protein (Fig. S1A) . In contrast, the NMDAmediated decrease in surface GABA B1b protein was not inhibited in the presence of , an inactive structural analog of KN-93 (10 μM for 10 min; NMDA + KN-92: 48.9 ± 7.9% of control, n = 9, P < 0.01; Fig. 2A ). Biotinylation experiments with cultured cortical neurons demonstrated that surface levels of endogenous GABA B subunits were significantly less reduced when NMDA was applied in the presence of KN-93 (GB1b: 80.3 ± 6.2% of control, P > 0.05 versus control, P < 0.05 versus NMDA alone; GB1a: 91.7 ± 4.1% of control, P > 0.05 versus control, P < 0.05 versus NMDA; GB2: 89.2 ± 3.0% of control, P > 0.05 versus control, P < 0.01 versus NMDA; n = 3; ANOVA with Tukey's multiple comparison test; Fig. 2B ). Thus KN-93 also interferes with NMDAmediated internalization of endogenous GABA B subunits.
S867 in GABA B1 Is Phosphorylated by CaMKII. Both anti-GABA B1 and anti-GABA B2 antibodies efficiently coimmunoprecipitated CaMKII from purified mouse brain membranes, whereas control sera did not (Fig. 2C) . This indicates that CaMKII associates with the GABA B1 and/or GABA B2 subunits of heteromeric GABA B receptors (29) . We corroborated this finding by performing pulldown assays with GST fusion proteins encoding the GABA B1 and GABA B2 C-termini (GST-GB1, GST-GB2). CaMKII in wholebrain lysate associated to a larger extent with GST-GB1 than with GST-GB2, supporting that CaMKII preferentially associates with GABA B1 (Fig. 2D) . For in vitro phosphorylation, the GST-fusion proteins were incubated for 30 min at 30°C with [γ-
32 P]-ATP and recombinant CaMKII. CaMKII-dependent phosphorylation was detectable on GST-GB1 but not on GST-GB2 or GST alone (Fig. 2E) . Thus CaMKII associates with native GABA B receptors and phosphorylates site(s) in the C terminus of GABA B1 .
To identify the CaMKII phosphorylation site(s) in GABA B1 , we digested phosphorylated GST-GB1 protein with LysC and trypsin, separated the resulting peptides by reverse-phase HPLC (RP-HPLC) and collected fractions at 1-min intervals (Fig. 3A) . The majority of radiolabel eluted in a single peak in fraction 54, which we further analyzed using electrospray ionization mass spectrometry (ESI-MS/MS). Database searches of the ESI-MS/ MS scans revealed the presence of the phosphopeptide GEWQ-SETQDTMK (the methionine of which was oxidized). The fragmentation spectrum indicated phosphorylation of the serine residue corresponding to S867 in the full-length GABA B1a protein (Fig. 3B) . S867 is localized in the juxtamembrane domain, a regulatory region for many transmembrane proteins, including Gprotein-coupled receptors (30) . S867 does not conform to the consensus sequence for phosphorylation by CaMKII (31) or other kinases (Table S1 ). Nonetheless, alanine substitution of putative phosphorylation sites within the GEWQSETQDTMK motif (GST-GB1S867A, GST-GB1T869A, GST-GB1T872A, GST-GB1T869A/T872A) confirmed that recombinant CaMKII only phosphorylates S867 in this sequence (Fig. 3C ). In addition, we found that CaMKII in brain extracts also specifically phosphorylates S867 in GST-GB1 (Fig. S3) . To analyze S867 phosphorylation in native tissue, we generated a S867 phosphorylation-state specific antibody, anti-GB1pS867. After phosphorylation of GST fusion proteins with recombinant CaMKII this antibody labeled GST-GB1 but not GST-GB1S867A (Fig. S4A) . No S867 phosphorylation was seen when using recombinant PKC instead of CaMKII for phosphorylation (Fig. S4B) . Importantly, the anti-GB1pS867 antibody revealed weak basal S867 phosphorylation (i) in mouse brain membranes after enrichment of GABA B receptors by immunoprecipitation and (ii) in synaptic plasma membranes after subcellular fractionation (Fig. 4 A and B) . Application of NMDA to cultured cortical neurons significantly increased phosphorylation of S867 (Fig. 4C) . Phosphorylation of S867 in brain membranes or cortical neurons was detectable only in the GABA B1b subunit isoform. However, we cannot exclude that NMDA treatment also weakly phosphorylates the GABA B1a subunit and that this phosphorylation is below our detection limit. Of note, GABA B(1b,2) but not GABA B(1a,2) receptors reside in spines (10) where NMDA and GABA B receptors are particularly abundant 32 P]-ATP. Phosphorylated proteins were separated by SDS/PAGE and exposed to autoradiography. Substitution of S867 with alanine in GST-GB1S867A prevented phosphorylation by CaMKII, whereas alanine substitutions of other putative phosphorylation sites in proximity of S867 (GST-GB1T869A, GST-GB1T872A and GST-GB1T869A/T872A) did not. Coomassie blue staining controlled for loading. (15) . This may explain why NMDA receptor activation preferentially targets GABA B1b for phosphorylation.
Removal of Surface GABA B Receptors Requires S867 Phosphorylation.
Cultured hippocampal neurons expressing HA-GB1b-eGFP or HA-GB1bS867A-eGFP in combination with exogenous GABA B2 were analyzed for surface expression of transfected GABA B1b protein (Fig. 4D and Fig. S5 ). HA-GB1bS867A-eGFP exhibited a similar surface expression level as HA-GB1b-eGFP, showing that lack of S867 phosphorylation does not prevent surface expression. However, HA-GB1bS867A-eGFP was refractory to removal from the surface upon NMDA treatment, as determined by the ratio of surface to total fluorescence intensity (GB1b NMDA: 52.6 ± 4.8%, n = 10, P < 0.01; GB1bS867A control: 82.4 ± 6.3%, n = 9, P > 0.05; GB1bS867A NMDA: 98.1 ± 16.0, n = 8, P > 0.05; data normalized to GB1b control; Fig. 4D ). This implicates S867 phosphorylation in GABA B receptor removal from the cell surface.
NMDA-Mediated CaMKII Activation Reduces GABA B -Induced K + Currents. Well-known effectors of dendritic GABA B receptors are the Kir3-type K + channels, which cluster with GABA B receptors in spines (12) . We used whole-cell patch-clamp recording to address whether NMDA-treatment reduces baclofen-induced K + currents due to GABA B receptor internalization. Baclofenevoked K + currents were recorded from cultured hippocampal neurons clamped at −50 mV after pharmacological blockade of Na + channels, GABA A , glycine, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and kainate receptors (Fig.  5A ). Baclofen-induced K + currents were recorded before and 30 min after NMDA treatment (30 μM NMDA/5 μM glycine in Mg 2+ -free solution for 1 min). During NMDA applications, neurons were held at −70 mV to minimize Ca 2+ entry through voltagegated Ca 2+ channels. Following NMDA treatment, the maximal amplitudes of the baclofen-induced K + currents were reduced (19.1 ± 6.5%, n = 5; Fig. 5C ). Likewise, baclofen-induced K + currents was decreased following glutamate treatment (5 μM glutamate/5 μM glycine in Mg 2+ -free solution for 1 min; 35.2 ± 5.1%, n = 3), and this decrease was prevented by the NMDA-receptor antagonist dCPP (20 μM; 93.5 ± 0.5%, n = 3, P < 0.001 compared with NMDA alone; Fig. 5 A and C) . Intracellular dialysis with the CaMKII inhibitor KN-93 (5 μM) significantly attenuated the NMDA-mediated reduction of K + currents (65.5 ± 9.0%, n = 5, P < 0.001 compared with NMDA alone). Ca 2+ /calmodulin-dependent protein kinase kinase β (CaMKKβ) promotes phosphorylation of the GABA B2 subunit by 5′AMP-dependent protein kinase (32) . Intracellular dialysis with the CaMKK inhibitor STO-609 (5 μM) resulted in a modest attenuation of NMDA-mediated reduction of K + -currents that, however, did not reach significance (41.3 ± 2.9%, n = 5, P > 0.05 compared with NMDA alone; Fig. 5 A and C). We next addressed whether phosphorylation at S867 is critical for the NMDA-mediated decrease in K + -current amplitude. We transfected cultured hippocampal neurons from GABA B1
) mice (33) with expression constructs for GABA B1b (GB1b), GABA B1a (GB1a) or GB1bS867A. All exogenous GABA B1 subunits, including GB1bS867A, fully rescued GABA B receptor function, demonstrating that they heteromerize with endogenous GABA B2 subunits ( Fig. 5 B and D) . In GB1 −/− neurons reconstituted with GB1b, NMDA application decreased the baclofen-induced K + currents to a similar extent as in wild-type neurons. In contrast, in GB1 −/− neurons reconstituted with GB1a or GB1bS867A NMDA application decreased the K + currents significantly less (GB1b: 28.3 ± 3.0%, n = 5; GB1a: 54.2 ± 7.2%, n = 6, P < 0.05; GB1bS867A: 64.1 ± 7.0%, brain membranes. S867 phosphorylation was detected on Western blots with a phosphorylation-state specific antibody (anti-GB1pS867). The same blot was reprobed with anti-GB1 antibodies. Immunoprecipitation with rabbit IgG (IP:IgG) was used as a control. Note the specific phosphorylation of the GABA B1b subunit. (B) S867 phosphorylation of GABA B1b was clearly detectable in synaptic plasma membranes (SPM) and barely detectable in the P2 membrane fraction purified from total mouse brain homogenates. (C) NMDA application to cultured cortical neurons increased S867 phosphorylation in the GABA B1b subunit. Neurons were treated with NMDA for 3 min and harvested at the times indicated. Whole-cell lysates (input) were subjected to immunoprecipitation with anti-GB1 antibodies (IP:GB1). S867 phosphorylation was detected on Western blot with anti-GB1pS867; antitubulin antibodies were used as control. (D) Alanine mutation of S867 in GABA B1b prevents NMDA-induced internalization. Cultured hippocampal neurons expressing exogenous HA-GB1b-eGFP (GB1b) or HA-GB1bS867A-eGFP (GB1bS867A) together with GABA B2 were analyzed at DIV14. Surface GABA B1b protein was quantified by the ratio of surface to total fluorescence intensity. Values were normalized to GB1b control in the absence of NMDA.
Data are means ± SEM, n = 8-10. **P < 0.01. transfected with GB1a or GB1bS867A than with GB1b. Maximal K + -current amplitudes after NMDA application were normalized to the maximal K + -current amplitudes before NMDA application. Data are means ± SEM, n = 3-6. *P < 0.05; **P < 0.01; ***P < 0.001. n = 5, P < 0.01). Thus predominantly phosphorylation of GABA B1b at S867 is implicated in the NMDA-mediated decrease of the K + -current amplitude.
NMDA-Mediated Endocytosis of GABA B Receptors in Dendritic Shafts
and Spines. GABA B(1b,2) receptors, which appear to be the main substrate for S867 phosphorylation, resides in dendritic spines and shafts (10) . We therefore addressed whether GABA B receptors at these locations internalize in response to NMDA. We transfected GABA B1b fused to a pH-sensitive eGFP [Super Ecliptic pHluorin (SEP-GB1b)] together with GABA B2 into organotypic hippocampal slice cultures. SEP-GB1b selectively visualizes GABA B1b protein at the cell surface (34) . In addition, we expressed the freely diffusible red fluorescent protein (RFP) t-dimer2 to visualize the morphology of transfected cells (10) . Time-lapse two-photon images of transfected CA1 pyramidal cells were collected at days in vitro (DIV) 14-21 (Fig. 6A ). Dendrites were imaged at 5-min intervals before and after bath application of NMDA (30 μM for 1 min). NMDA application resulted in a long-lasting decrease in green fluorescence in dendritic spines and shafts, indicating GABA B receptor internalization (Fig. 6 B and C, green traces; SEP-GB1b fluorescence ratio after/before NMDA: spine, 0.82 ± 0.05, n = 22, P < 0.001; shaft, 0.73 ± 0.04, n = 8, P < 0.001; nonparametric Mann-Whitney test; five cells analyzed). NMDA application did not significantly affect RFP fluorescence in dendritic spines and shafts ( Fig. 6 B and C, red traces; RFP fluorescence ratio after/before NMDA: spine, 1.04 ± 0.05, n = 22, P > 0.05; shaft, 0.88 ± 0.03, n = 8, P > 0.05). The decrease in green fluorescence was inhibited in the presence of the NMDA receptor antagonist dCPP (20 μM; Fig. 6 B and C, green traces; SEP-GB1b fluorescence ratio after/before NMDA: spine, 1.00 ± 0.05, n = 15, P > 0.05; shaft, 0.99 ± 0.04, n = 3, P > 0.05; 2 cells analyzed). No significant change in the red fluorescence under NMDA receptor blockade was observed ( Fig. 6 B and C, red traces; RFP fluorescence ratio after/ before NMDA: spine, 1.06 ± 0.07, n = 15, P > 0.05; shaft, 1.02 ± 0.03, n = 3, P > 0.05). Thus NMDA receptor stimulation leads to GABA B receptor internalization in dendritic spines and shafts. In agreement with experiments described above (Figs. 4D and 5D and Fig. S5B ) the SEP-GB1bS867A protein is refractory to NMDAinduced internalization in dendritic spines and shafts (Fig. S6) .
Discussion
Activity-Dependent Phosphorylation and Internalization of Dendritic GABA B Receptors. A previous report showed that glutamate application to cortical neurons decreases the number of GABA B receptors at the cell surface (18) . Another report showed that glutamate application increases the steady-state level of GABA B receptor endocytosis while at the same time reducing the rate of endocytosis (35) . Here, we show that glutamate acts via NMDA receptors to activate CaMKII (36) , which directly phosphorylates S867 in the C terminus of GABA B1 to trigger endocytosis. NMDAdependent phosphorylation of S867 is detectable only in the GABA B1b subunit, which mostly resides in the dendrites and, in contrast to the GABA B1a subunit, efficiently penetrates spines (10) . Consistent with this, we found that GABA B receptors undergo endocytosis in dendritic spines and shafts within minutes of NMDA receptor activation. Notably, endocytosis prevents GABA B receptors from activating effector K + channels that cluster with GABA B receptors in spines (12) .
Physiological Implications. GABA from interneurons firing in synchrony can spill over to pre-and postsynaptic GABA B receptors on excitatory synapses (11, 37) . This will reduce glutamate release and produce hyperpolarizing inhibitory postsynaptic potentials that enhance Mg 2+ block of NMDA receptors and thus reduce their Ca 2+ signals (13, 14) . In addition to modulating the electrical properties of neurons, GABA B receptors can also reduce the Ca 2+ permeability of NMDA receptors in dendritic spines via activation of the PKA signaling pathway (15) . Here, we demonstrate that NMDA receptors can counter this suppression of Ca 2+ signals and rapidly endocytose GABA B receptors from the surface of dendritic shafts and spines. Hence, there appears to be a reciprocal regulation where both NMDA and GABA B receptors can cancel each other out. The temporal interplay of NMDA and GABA B receptors may be particularly relevant to phenomena controlling synaptic strength, where NMDA receptor activity is of importance. Of note, the same NMDA receptor/CaMKII signaling cascade regulating synaptic strength also internalizes GABA B receptors. This provides a means to keep individual glutamatergic synapses modifiable (38, 39) and to spare them from inhibition through spillover of GABA. A previous study reported that NMDA receptor activation promotes surface expression of Kir3 channels in hippocampal neurons (40) , which was paralleled with an increase in basal Kir3 currents and adenosine A 1 -mediated Kir3 currents (41) . However, GABA B mediated Kir3 currents were not altered, in apparent conflict with an earlier report (42) and our own findings. The reasons for these discrepancies are unclear but may relate to differences in the signaling pathways activated under the different experimental conditions used. Reciprocal regulation of NMDA and GABA B receptors is reminiscent of the recently , and G/R ratio images of dendrites expressing freely diffusible RFP and SEP-GB1b before and after NMDA application. NMDA application leads to a decrease in green fluorescence in dendritic spines and shafts. G/R ratio is coded in rainbow colors and is scaled to encompass 2 SDs (2σ) of the average dendritic ratio before NMDA application.
(Scale bar, 5 μm.) (B and C) Time course of red and green fluorescence in dendritic spines (B) and shafts (C) before and after NMDA application. NMDA leads to a long-lasting decrease in SEP-fluorescence within minutes, which is prevented by prior application of dCPP. Data are mean ± SEM.
